Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 3/20 | 0.52 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.52 |
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 3/20 | 0.44 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.42 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.42 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.42 |
| ▸ | MMP2 | P08253 | 2/20 | 0.42 |
| ▸ | ATG4B | Q9Y4P1 | 2/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
| ▸ | RAD52 | P43351 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2397949 | 1.00 | FFAR1 (0.52) | FFAR1FFAR4GPR84TSHRFAAH | |
| SCHEMBL9334962 | 1.00 | FFAR1 (0.52) | FFAR1FFAR4GPR84TSHRFAAH | |
| SCHEMBL11748318 | 1.00 | FFAR1 (0.52) | FFAR1FFAR4GPR84TSHRFAAH | |
| SCHEMBL9200158 | 1.00 | FFAR1 (0.52) | FFAR1FFAR4GPR84TSHRFAAH | |
| SCHEMBL1712736 | 1.00 | FFAR1 (0.52) | FFAR1FFAR4GPR84TSHRFAAH | |
| SCHEMBL1712990 | 1.00 | FFAR1 (0.52) | FFAR1FFAR4GPR84TSHRFAAH | |
| SCHEMBL9685588 | 1.00 | FFAR1 (0.52) | FFAR1FFAR4GPR84TSHRFAAH | |
| SCHEMBL9685329 | 1.00 | FFAR1 (0.52) | FFAR1FFAR4GPR84TSHRFAAH | |
| SCHEMBL7065643 | 1.00 | FFAR1 (0.52) | FFAR1FFAR4GPR84TSHRFAAH | |
| SCHEMBL9200169 | 1.00 | FFAR1 (0.52) | FFAR1FFAR4GPR84TSHRFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4779121-B2 | — | — | 2011-09-28 | — | — | JP | claimed |
| EP-1673328-B1 | AN IMPROVED PROCESS FOR THE SYNTHESIS OF UNSATURATED ALCOHOLS | DOW GLOBAL TECHNOLOGIES INC (US) | 2008-07-09 | — | — | EP | claimed |
| JP-2007508300-A | — | — | 2007-04-05 | — | — | JP | claimed |
| US-7176336-B2 | Preparing 9-octadecene-7,12-diol by catalyzing methyl ricinoleate derived from a seed oil, in presence of a metathesis catalyst; improved yield; use in manufacture of surfactants and thermoplastic polyurethanes | DOW GLOBAL TECHNOLOGIES INC. (US) | 2007-02-13 | — | — | US | claimed |
| EP-1673328-A2 | AN IMPROVED PROCESS FOR THE SYNTHESIS OF UNSATURATED ALCOHOLS | Dow Global Technologies Inc. (US) | 2006-06-28 | — | — | EP | claimed |
| WO-2005040077-A2 | AN IMPROVED PROCESS FOR THE SYNTHESIS OF UNSATURATED ALCOHOLS | DOW GLOBAL TECHNOLOGIES INC. (US) | 2005-05-06 | — | — | WO | claimed |
| US-20050080301-A1 | Process for the synthesis of unsaturated alcohols | DOW GLOBAL TECHNOLOGIES LLC | 2005-04-14 | — | — | US | claimed |
| US-20240417359-A1 | PRECURSORS OF PHENOLIC FRAGRANT COMPOUNDS | GIVAUDAN SA (CH) | 2024-12-19 | — | — | US | disclosed |
| CN-117126906-B | Modification method of soybean protein isolate, modified soybean protein isolate and application thereof | 中国农业大学 | 2024-10-25 | — | — | CN | disclosed |
| EP-4419498-A1 | PRECURSORS OF PHENOLIC FRAGRANT COMPOUNDS | Givaudan SA (CH) | 2024-08-28 | — | — | EP | disclosed |
| CN-118119589-A | Phenol aromatic compound precursor | 奇华顿股份有限公司 | 2024-05-31 | — | — | CN | disclosed |
| CN-117126906-A | Modification method of soybean protein isolate, modified soybean protein isolate and application thereof | 中国农业大学 | 2023-11-28 | — | — | CN | disclosed |
| WO-2023067040-A1 | PRECURSORS OF PHENOLIC FRAGRANT COMPOUNDS | GIVAUDAN SA (CH) | 2023-04-27 | — | — | WO | disclosed |
| EP-0841090-A2 | Catalyst and process for production of 2-buten-1-ol compounds | BASF AKTIENGESELLSCHAFT (DE) | 1998-05-13 | — | — | EP | disclosed |
| US-4310709-A | SELENIUM OR TELLURIUM MODIFIED PALLADIUM CATALYST | BASF AKTIENGESELLSCHAFT (DE) | 1982-01-12 | — | — | US | disclosed |
| US-4219683-A | USING A PALLADIUM-THORIUM OXIDE CATALYST | PHILLIPS PETROLEUM COMPANY (US) | 1980-08-26 | — | — | US | disclosed |
| EP-0002027-B1 | PROCESS FOR THE PREPARATION OF 2-BUTENE-1-OL COMPOUNDS BY ISOMERIZATION OF THE CORRESPONDING 3-BUTENE-1-OL COMPOUNDS | BASF Aktiengesellschaft (DE) | 1980-07-23 | — | — | EP | disclosed |
| EP-0002027-A1 | Process for the preparation of 2-butene-1-ol compounds by isomerization of the corresponding 3-butene-1-ol compounds | BASF Aktiengesellschaft (DE) | 1979-05-30 | — | — | EP | disclosed |
| US-4040977-A | HALOACETAMIDE OR THIOCYANOACETAMIDE-ALCOHOL-FORMALDEHYDE CONDENSATES | STERLING DRUG INC. (US) | 1977-08-09 | — | — | US | disclosed |
| US-4039585-A | Hydroformylation process | UOP INC. (US) | 1977-08-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050080301-A1 | Process for the synthesis of unsaturated alcohols | FASN, SQLE, ALOX12 | FFAR1 119/4885FFAR4 189/4885GPR84 1361/4885 |
| US-20240417359-A1 | PRECURSORS OF PHENOLIC FRAGRANT COMPOUNDS | HAAO, FOS, HPD | FFAR1 562/4885FFAR4 822/4885GPR84 1890/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.